HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shinji Tanaka Selected Research

Pepsinogen A (Pepsinogen)

10/2015Diagnosis of Helicobacter pylori-induced gastritis by serum pepsinogen levels.
2/2014Advanced method for evaluation of gastric cancer risk by serum markers: determination of true low-risk subjects for gastric neoplasm.
9/2011Helicobacter pylori cagA polymorphism and gastric inflammation: an international comparison between Japanese and Brazilian patients.
6/2007Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.
4/2007Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
9/2006Helicobacter pylori infection is the major risk factor for gastric inflammation in the cardia.
1/2004Mucin phenotype and background mucosa of intramucosal differentiated-type adenocarcinoma of the stomach.
1/2003Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
5/2002Implication of anti-parietal cell antibody levels in gastrointestinal diseases, including gastric carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Shinji Tanaka Research Topics

Disease

114Neoplasms (Cancer)
02/2016 - 01/2002
42Hepatocellular Carcinoma (Hepatoma)
09/2015 - 01/2002
35Neoplasm Metastasis (Metastasis)
02/2015 - 01/2002
27Carcinoma (Carcinomatosis)
03/2015 - 11/2002
21Stomach Neoplasms (Stomach Cancer)
02/2015 - 05/2002
19Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 01/2002
12Hemorrhage
10/2015 - 03/2003
12Gastritis
10/2015 - 07/2002
11Infection
01/2015 - 01/2003
9Inflammation
04/2015 - 01/2005
7Colonic Neoplasms (Colon Cancer)
02/2015 - 01/2002
7Crohn Disease (Crohn's Disease)
01/2015 - 01/2005
7Ulcer
01/2014 - 05/2009
7Microsatellite Instability
01/2014 - 09/2003
6Adenoma (Adenomas)
05/2015 - 10/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2009 - 11/2002
5Polyps
03/2015 - 10/2003
5Anoxia (Hypoxia)
12/2014 - 06/2003
5Cardiovascular Diseases (Cardiovascular Disease)
10/2013 - 01/2008
4Atrophy
10/2015 - 05/2008
4Proteinuria
04/2015 - 12/2009
4Adenocarcinoma
11/2014 - 01/2004
4Fibrosis (Cirrhosis)
09/2014 - 03/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
07/2012 - 11/2004
4Esophageal Neoplasms (Esophageal Cancer)
10/2007 - 12/2002
3Polyploidy
09/2015 - 01/2010
3Ulcerative Colitis
05/2015 - 01/2015
3Kidney Diseases (Kidney Disease)
04/2015 - 02/2010
3Liver Diseases (Liver Disease)
05/2014 - 06/2010
3Peripheral Arterial Disease
01/2014 - 08/2010
3Hepatitis
11/2013 - 01/2002
3Pathologic Constriction (Stenosis)
09/2013 - 09/2007
3Ischemia
08/2012 - 08/2010
3Chronic Hepatitis C
07/2012 - 05/2011
2Body Weight (Weight, Body)
09/2015 - 08/2010
2Colitis
09/2015 - 01/2005
2Diarrhea
01/2015 - 12/2009

Drug/Important Bio-Agent (IBA)

18Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2014 - 11/2002
13glucuronyl glucosamine glycan sulfate (Vessel)IBA
08/2015 - 11/2002
13Messenger RNA (mRNA)IBA
06/2013 - 11/2002
11DNA (Deoxyribonucleic Acid)IBA
07/2015 - 01/2005
10alpha-Fetoproteins (AFP)IBA
12/2014 - 01/2002
9Pepsinogen A (Pepsinogen)IBA
10/2015 - 05/2002
8Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2015 - 06/2006
7Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2015 - 01/2008
7Vascular Endothelial Growth Factor CIBA
11/2008 - 01/2002
6N-methylsuccinimideIBA
01/2014 - 09/2003
6Mitochondrial DNA (mtDNA)IBA
01/2014 - 08/2003
6InterleukinsIBA
06/2013 - 11/2003
6GastrinsIBA
03/2013 - 09/2006
6ParaffinIBA
12/2010 - 06/2003
5Biological Markers (Surrogate Marker)IBA
10/2015 - 01/2003
5Phosphotransferases (Kinase)IBA
08/2015 - 04/2002
5Vascular Endothelial Growth Factor DIBA
10/2010 - 01/2004
4aurora kinase (aurora A kinase)IBA
09/2015 - 01/2010
4CytokinesIBA
09/2015 - 03/2005
4infliximab (Remicade)FDA Link
02/2014 - 01/2005
4MucinsIBA
10/2012 - 01/2004
4InterferonsIBA
07/2012 - 05/2011
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2012 - 11/2002
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2015 - 05/2011
3ChromatinIBA
01/2015 - 01/2013
3Prednisolone (Predate)FDA LinkGeneric
01/2015 - 01/2011
3tranilast (N 5')IBA
08/2014 - 07/2007
3Calcibiotic Root Canal SealerIBA
04/2014 - 10/2003
3Fluorouracil (Carac)FDA LinkGeneric
04/2014 - 09/2004
3gemcitabineFDA Link
01/2014 - 11/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2013 - 01/2002
3CreatinineIBA
03/2013 - 08/2010
3MicroRNAs (MicroRNA)IBA
02/2013 - 05/2010
3OxygenIBA
08/2012 - 08/2010
3Ribavirin (Virazole)FDA LinkGeneric
07/2012 - 05/2011
3Complementary DNA (cDNA)IBA
10/2010 - 09/2004
3Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
10/2010 - 01/2004
3AntibodiesIBA
05/2007 - 01/2003
3beta CateninIBA
11/2005 - 12/2002
3Thymidine PhosphorylaseIBA
02/2004 - 01/2003
22- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA
09/2015 - 01/2010
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
08/2015 - 07/2006
2Prothrombin (Factor II)IBA
07/2015 - 05/2014
2everolimusFDA Link
02/2015 - 12/2013
24- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib)FDA Link
02/2015 - 12/2013

Therapy/Procedure

16Hepatectomy
12/2014 - 05/2003
13Drug Therapy (Chemotherapy)
03/2016 - 12/2004
6Heterologous Transplantation (Xenotransplantation)
09/2015 - 01/2002
5Aftercare (After-Treatment)
03/2015 - 09/2011
4Endoscopes
10/2014 - 09/2007
4Renal Dialysis (Hemodialysis)
10/2013 - 04/2011
3Oral Administration
09/2015 - 01/2005
3Lasers (Laser)
02/2015 - 01/2005
3Pancreaticoduodenectomy
05/2014 - 07/2011
3Surgical Instruments (Clip)
03/2014 - 10/2005
3Transplantation (Transplant Recipients)
02/2013 - 01/2009
3Transplants (Transplant)
12/2012 - 03/2010
3Molecular Targeted Therapy
08/2012 - 07/2010
3Stents
04/2009 - 05/2003
3Catheters
09/2008 - 03/2003
2Colonoscopes
05/2015 - 03/2013
2Colectomy
01/2015 - 12/2009
2Endoscopic Hemostasis
01/2015 - 01/2012